AbbVie (NYSE: ABBV) is scheduled to announce its financial results for the fourth quarter of 2025 before the market opens on Wednesday, February 4. Analysts forecast the company will report earnings of $3.37 per share and revenue totaling approximately $16.39 billion for the quarter.
Investors and analysts will be closely watching the report for insights into AbbVie’s recent performance and outlook. The company’s earnings summary page will provide updated information following the release.
**Why this matters**
AbbVie’s quarterly results are significant for stakeholders as they reflect the company’s operational health and growth trajectory. The earnings report can influence investor sentiment and impact the stock’s performance in the market.
Source: NewsData